These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9492778)

  • 21. Human immunodeficiency virus-infected boy with Stevens-Johnson syndrome caused by nevirapine.
    Oberdorfer P; Washington CH; Jittamala P
    Pediatr Infect Dis J; 2008 Jun; 27(6):572. PubMed ID: 18458648
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV-1 infected patients with toxic epidermal necrolysis: an occupational risk for healthcare workers.
    Descamps V; Tattevin P; Descamps D; L'Heriteau F; Schortgen F; Regnier B
    Lancet; 1999 May; 353(9167):1855-6. PubMed ID: 10359421
    [No Abstract]   [Full Text] [Related]  

  • 23. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
    Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
    AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxic epidermal necrolysis associated with abacavir].
    Montero M; García-Gibert L; Giménez-Arnau AM; Knobel H
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):247. PubMed ID: 15826554
    [No Abstract]   [Full Text] [Related]  

  • 25. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
    Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
    Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
    [No Abstract]   [Full Text] [Related]  

  • 26. Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?
    Morlese JF; Qazi NA; Gazzard BG; Nelson MR
    AIDS; 2002 Sep; 16(13):1840-1. PubMed ID: 12218402
    [No Abstract]   [Full Text] [Related]  

  • 27. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
    Santos RP; Ramilo O; Barton T
    Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxis.
    Bannaga A; Rahama O; Barlow G
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23625676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
    Daniel OJ; Krain AB; Ogun SA; Odusoga OL; Boyle BA
    J Natl Med Assoc; 2005 Dec; 97(12):1719-21. PubMed ID: 16396066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe hepatic and cutaneous adverse effects with nevirapine.
    Prescrire Int; 2000 Aug; 9(48):116. PubMed ID: 11067724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of rash and discontinuation of nevirapine using two different escalating initial doses.
    Antón P; Soriano V; Jiménez-Nácher I; Rodriguez-Rosado R; Dona MC; Barreiro PM; González-Lahoz J
    AIDS; 1999 Mar; 13(4):524-5. PubMed ID: 10197383
    [No Abstract]   [Full Text] [Related]  

  • 32. Nevirapine-induced Stevens-Johnson syndrome in an HIV patient.
    Jain V; Shome D; Natarajan S
    Cornea; 2008 Apr; 27(3):366-7. PubMed ID: 18362670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV
    Ter Arkh; 2004; 76(11):68-71. PubMed ID: 15658542
    [No Abstract]   [Full Text] [Related]  

  • 35. Stevens - Johnson syndrome due to nevirapine.
    Namayanja GK; Nankya JM; Byamugisha JK; Ssali FN; Kityo CM; Rwambuya SD; Mugerwa RD; Mmiro FA; Morrison CS; Salata RA
    Afr Health Sci; 2005 Dec; 5(4):338-40. PubMed ID: 16615847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():58-60. PubMed ID: 15373051
    [No Abstract]   [Full Text] [Related]  

  • 37. Nevirapine-induced hepatitis treated with corticosteroids?
    Leitze Z; Nadeem A; Choudhary A; Saul Z; Roberts I; Manthous CA
    AIDS; 1998 Jun; 12(9):1115-7. PubMed ID: 9662216
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spanish study looks at the effect of nevirapine on the liver.
    TreatmentUpdate; 2001 Jul; 13(3):4-5. PubMed ID: 11569988
    [No Abstract]   [Full Text] [Related]  

  • 40. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May; 94(5):338. PubMed ID: 15211947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.